Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
A phase 3 trial of Gemcitabine, Vinorelbine, Paclitaxel / nab-paclitaxel, Pemetrexed, H101 oncolytic adenovirus, Recombinant human endostatin and Cisplatin in Non-small-cell lung cancer, run by Xinqiao Hospital of Chongqing, with a status the registry has not verified recently.
Overview
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients is a phase 3 interventional study registered as NCT02579564 by Xinqiao Hospital of Chongqing, with 134 participants planned, started 2016-10 and due to reach its primary completion in 2018-06. Interventions recorded: Gemcitabine, Vinorelbine, Paclitaxel, Pemetrexed, Oncorine, Endostar, Cisplatin. Conditions recorded: Malignant Hydrothorax, Non Small Cell Lung Cancer.
Linked to the drug H101 oncolytic adenovirus because the registry names it among its interventions and Non-small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialAdjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
Shares Recombinant human endostatin, Non-small-cell lung cancer and the tag pipeline.
- TrialAdjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)
Shares Recombinant human endostatin, Non-small-cell lung cancer and the tag pipeline.
- TrialCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Shares Vinorelbine, Paclitaxel / nab-paclitaxel, Cisplatin, Non-small-cell lung cancer and the tag pipeline.
- TrialNivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Shares Pemetrexed, Gemcitabine, Paclitaxel / nab-paclitaxel, Cisplatin and the tag pipeline.
- TrialH101 Plus TACE for r/m HNSCC
Shares H101 oncolytic adenovirus and the tag pipeline.
- TrialHAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B
Shares H101 oncolytic adenovirus and the tag pipeline.
- TrialA Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Shares Pemetrexed, Gemcitabine, Cisplatin, Non-small-cell lung cancer and the tag pipeline.
- TrialA Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Shares Vinorelbine, Gemcitabine, Non-small-cell lung cancer and the tag pipeline.